New drug combo may reduce severe transplant complications in blood cancer patients
Disease control
Completed
This study tested whether a combination of two drugs, cyclophosphamide and abatacept, could lower the risk of chronic graft-versus-host disease (GVHD) after a stem cell transplant for high-risk blood cancers. GVHD happens when donor cells attack the patient's body. The trial enro…
Phase: PHASE2 • Sponsor: Dimitrios Tzachanis, MD PhD • Aim: Disease control
Last updated Jun 15, 2026 19:02 UTC